Related by context. All words. (Click for frequent words.) 85 sodium thiosulfate STS 77 Prodarsan R 77 MKC# MT 76 CYT# potent vascular disrupting 76 recombinant PSMA vaccine 75 PORxin TM platforms 75 Syndax Pharmaceuticals Inc. 75 kidney urologic 75 pharmacogenomic translational research 75 MCSP respectively 74 Exherin TM 74 sarcoma melanoma 74 lintuzumab SGN 74 leading oral taxane 74 VEGFR2 inhibitor 74 LymphoStat B TM 73 AAG geldanamycin analog 73 GEM OS2 73 catheter occlusion 73 Initiates Enrollment 73 Bayer HealthCare Onyx Pharmaceuticals 73 GVAX ® 73 CD# CEA 73 hypoxia activated prodrug 73 candidate CRLX# 73 LymphoStat B belimumab 73 oncolytic virus therapies 73 Zemiva TM 73 orally inhaled migraine 72 Completes Patient Enrollment 72 PI3K/Akt pathway inhibitor 72 Personalized Immunotherapy 72 albiglutide 72 XL# anticancer compounds 72 acyclovir Lauriad R 72 Provectus Pharmaceuticals specializes 72 TELINTRA R 72 Panzem R NCD 72 candidate deforolimus 72 SinuNase TM 72 SinuNase ™ 72 rxRNA 72 Phase #b/#a clinical 72 Xcytrin R 72 oral nucleoside analogue 71 Initiate Phase 71 antiangiogenesis therapies 71 oral prodrug 71 FOLOTYN ® 71 candidate XP# 71 metaglidasen 71 Pivotal Phase III 71 INS# [001] 71 targeted radiotherapeutic 71 muscarinic receptor agonist 71 novel therapeutic antibodies 71 docetaxel Taxotere ® 71 novel VDA molecule 71 Pivotal Phase 71 Exelixis compounds 71 HGS ETR1 mapatumumab 71 2 methoxyestradiol 71 Solazed 71 trastuzumab DM1 T DM1 71 telomerase therapeutic 71 Meets Primary Endpoint 71 MKC# 71 PGL# 71 QNEXA ® 71 Cloretazine ® 71 evaluating picoplatin 71 personalized cellular immunotherapy 71 sapacitabine CYC# 71 Initiates Phase II 71 Initiated Phase 71 Archexin 71 Augment TM 71 TKB# 71 Hedgehog Pathway Inhibitor 71 oral picoplatin 71 dasatinib Sprycel ® 71 alfimeprase direct 71 delta opioid receptor 71 mecarbil 70 Files IND 70 Myocet 70 candidates Azedra TM 70 Solazed TM 70 Aflibercept 70 receptor tyrosine kinase inhibitor 70 Combination REOLYSIN R 70 alvespimycin 70 Crofelemer budesonide foam 70 BrachySil TM 70 ALN PCS 70 Initiates Clinical Trial 70 candidate AQ4N 70 Reports Preclinical Data 70 AERx ® 70 TBC# 70 prokinetic agent 70 stage hypoxia activated 70 tiapamil 70 IMA# 70 TRANSDUR ® 70 myelofibrosis polycythemia vera 70 trial evaluating PRX# 70 CTAP# Capsules 70 interferon alpha IFN 70 Randomized Phase 70 topically applied SEPA 70 ALN VSP Phase 70 Vicinium TM 70 retinal vein occlusion induced 70 acetonide FA 70 MKC# MKC# PP 70 Evoltra ® 70 Sudhir Agrawal D.Phil 70 Initiate Clinical Trial 70 ONCONASE R 70 TNFerade TM 70 Tesetaxel 70 assessing T DM1 70 R sorafenib tablets 70 Panzem R 70 generation DACH Platinum 70 INxin TM 70 delivers fluocinolone acetonide FA 70 Brentuximab Vedotin SGN 70 testing huN# DM1 70 includes investigational compounds 70 mGluR5 negative 70 products MKC# PP 70 Rigel R# 70 forodesine 70 Phase IIb clinical trials 70 Phase 2b Clinical Trial 70 Matrix Phase 2b 70 treat chronic sinusitis 69 Achieves Primary Endpoint 69 rALLy 69 Begins Dosing 69 NU# direct 69 Rhucin ® recombinant 69 diarrhea predominant irritable 69 Quinamed R 69 OvaRex R 69 novel emulsion formulation 69 MEK Inhibitor 69 CCR9 antagonist 69 PANVAC VF 69 Kamada AAT 69 rALLy clinical trial 69 cMET 69 Cardiotoxicity 69 elotuzumab 69 thrombin component 69 XP# XP# 69 Phase III Pivotal 69 Proellex TM 69 ionotropic glutamate receptor antagonists 69 telomerase inhibitor drug 69 GW# [003] 69 Factor VIIa 69 phase III isavuconazole 69 Romidepsin 69 vinorelbine tartrate 69 vapreotide acetate 69 Oral NKTR 69 Initiates Phase III 69 cancer indications bafetinib 69 vitreoretinal disorders 69 Pruvel TM 69 immunological diseases 69 THR beta agonist 69 Cleviprex TM clevidipine 69 ALN HPN 69 Exherin 69 Phase 1b clinical trials 69 recombinant biopharmaceutical 69 Pharma Merck Serono 69 Selective Electrochemical Tumor Ablation 69 dyslipidemia hypertension diabetes 69 PDE# inhibitors 69 Syncria R 69 Pegloticase 69 BENLYSTA ® 69 Zemiva ™ 69 POSIDUR TM ELADUR TM 69 PrevOnco 69 constipation OIC 69 TRIOLEX ™ 69 DEB# 69 Phase Ib II 69 Testosterone MDTS R 69 diagnostic molecular imaging 69 TRIOLEX HE# APOPTONE HE# 69 PSMA ADC 69 PMX # heptagonist 69 TNFerade ™ 69 generation purine nucleoside 69 MAGE A3 ASCI 69 molecular imaging radiopharmaceutical 69 Hormone Refractory Prostate Cancer 69 Annamycin 69 Presents Positive 69 LHRH receptor positive 69 GVAX R 69 mertansine 69 demonstrated antitumor activity 69 pralatrexate injection folate analogue 69 recurrent metastatic ovarian cancer 69 MGd 69 toenail onychomycosis 69 Angiocept 69 relapsed MM 69 Phase III Clinical Trial 69 include Phenoptin TM 69 lexidronam injection 69 serine protease inhibitor CU# 69 BRIM2 69 Safinamide 69 Entereg R 69 Metastatic Melanoma 69 data management Clintrial 69 XmAb ® 69 solid tumors ZYBRESTAT 69 vaccines oncolytic virus 69 ® bortezomib 69 Successfully Completes Phase 69 JZP 69 Testosterone MDTS ® 69 PDX pralatrexate 69 Panzem ® 69 inflammatory autoimmune diseases 69 oral ghrelin agonist 69 PrevOnco ™ 69 Commences Phase 69 diabetes irritable bowel 69 AFREZZA TM 69 oral proteasome inhibitor 68 stage antibody MT# 68 midstage clinical 68 Hsp# Inhibitor 68 multicenter Phase III 68 OTC BB PVCT http:/www.pvct.com 68 Ostabolin C TM 68 essential thrombocythemia ET 68 ALTROPANE R 68 Novel Oral 68 visit www.genenews.com 68 metastatic colorectal 68 product platforms AZX# 68 Dacogen injection 68 Aganocide 68 humanised monoclonal antibody 68 liposomal formulation 68 vinca alkaloid 68 Veronate R 68 including acne photodamage 68 sapropterin dihydrochloride Phase 68 R Saizen R 68 erlotinib Tarceva ® 68 myocardial infarction ventricular fibrillation 68 developing ACAPODENE 68 Immunotherapeutic 68 delivery polymer matrix 68 Allovectin 7 68 fusion enhancers 68 huC# DM4 68 Nanobody R 68 registrational Phase 68 galiximab 68 Inc. AMEX YMI 68 sorafenib tablets 68 development peramivir neuraminidase 68 Completes Enrollment 68 platforms GVAX 68 phase IIb clinical 68 protein tyrosine phosphatase 1B 68 Amigal TM 68 polycythemia vera essential thrombocythemia 68 RGB # 68 RhuDex TM 68 Ceflatonin R 68 budesonide foam 68 Naive Patients 68 thetreatment 68 dermatology biopharmaceutical company 68 AEG# 68 commercialize deforolimus 68 Nanobody 68 IMC #B 68 XL# XL# 68 Empatic ™ 68 SPRYCEL ® 68 brivanib 68 gastrin analogue TT 68 Azedra TM 68 carcinoma HCC 68 Cannabinor 68 markets Testim ® 68 dimebon latrepirdine 68 biliary tract cancer 68 nilotinib Tasigna ® 68 SYN# 68 AKT inhibitor 68 Vascular Disrupting Agent 68 Fludara ® 68 PNP inhibitor 68 next generation URAT1 68 cutaneous T 68 Phase 2a Clinical Trial 68 brand ciclesonide HFA 68 neuropathic pain metabolic diseases 68 approved incretin mimetic 68 unique alkylating agent 68 ospemifene 68 2 inhibitor CYT# 68 immunotherapeutic approaches 68 PDE4 inhibitor 68 EOquin TM phase 68 OvaRex ® MAb 68 Investigational Oral 68 Diabetic Macular Edema DME 68 refractory chronic lymphocytic 68 CRLX# 68 Vitrasert R 68 Combivir Kivexa 68 LEUKINE 68 FOLFOX6 chemotherapy regimen 68 R lenalidomide 68 Sapacitabine 68 Budesonide foam crofelemer 68 progressive metastatic prostate 68 hormone LHRH antagonist 68 gastrointestinal mucositis 68 Patients Treated With 68 papillary renal cell carcinoma 68 PRN FDA Approves 68 oxypurinol 68 orally administered inhibitor 68 docetaxel Taxotere R 68 NYSE Amex PBTH 68 Trofex 68 GERD migraine headaches 68 Trastuzumab DM1 68 Luramist TM 68 investigational monoclonal antibody 68 Hepatocellular Carcinoma HCC 68 GRN# 68 Demonstrates Positive 68 opioid naive 68 Stanate R 68 ADP receptor antagonist 68 SPL# Gel vaginal microbicide 68 Vidaza ® 68 Sphingomab TM 68 R#/MEM # 68 haematologic 68 ATPace TM 68 targeting miR 68 oral calcitonin licensed 68 aflibercept VEGF Trap 68 generation URAT1 inhibitor 68 Homspera TM 68 cardiac myosin activator omecamtiv 68 ELACYT 68 Alfacell proprietary ribonuclease 68 treat opioid induced 68 investigational antiplatelet agent 68 LungAlert TM 68 CYT# vascular disrupting 68 6 sulfatase 68 dextofisopam 68 commercialize CorMedix drug 68 Liprotamase 68 ocular formulation 68 acute peripheral arterial 68 ARRY # 68 Prednisone Against Refractory 67 LHRH antagonists 67 Panzem NCD 67 Ecallantide 67 ThermoDox R 67 EGFR HER2 67 OncoVex 67 investigational pan BCR 67 Glufosfamide 67 pharmacokinetic PK study 67 Amgen Neulasta R 67 RECORD1 67 Submits Biologics License Application 67 candidate TNFerade biologic 67 hoFH 67 TELINTRA 67 management biostatistical analysis 67 ChronVac C R 67 TRO# 67 Telatinib 67 Adjuvant Treatment 67 Initiates Clinical 67 methylnaltrexone bromide 67 tumors GIST 67 YONDELIS 67 PMX # antibiotic 67 IRX 2 67 CINQUIL 67 4SC AG ISIN DE# 67 cytomegalovirus immune globulin 67 IMiDs ® 67 bone marrow reticulin deposition 67 ularitide 67 Mg Usa 67 metastatic pancreatic 67 monoclonal antibody conjugated 67 Clinical Trial Results 67 JAK2 Inhibitor 67 Telik logo TELINTRA 67 antibiotic candidate Ramoplanin 67 relapsed leukemia 67 investigational compounds 67 PRT# 67 gastro intestinal inflammation 67 Elagolix 67 angiotensin analog 67 Pivotal Trial 67 Submits Response 67 drug pipeline TAFA# 67 candidates Augment ™ 67 vascular occlusive diseases 67 human IgG1 monoclonal 67 myelodysplastic myeloproliferative diseases 67 deforolimus 67 initiated Phase Ib 67 tolevamer 67 evaluating T DM1 67 alpha folate receptor 67 selective androgen receptor modulator 67 budesonide MMX Phase III 67 Severe Sepsis 67 EOquin TM 67 gastrointestinal disorders ATI 67 oral ridaforolimus 67 NASH Huntington 67 Survivin antagonist 67 induced macular edema 67 Prodarsan ® 67 TKM PLK1 67 hereditary emphysema 67 Phase Ib IIa 67 metastatic sarcomas 67 BRIM3 67 drugs FUSILEV 67 PROSTASCINT R 67 refractory gout 67 dasatinib Sprycel 67 humanized interleukin 6 67 compound INCB# 67 modified glutathione analog 67 Dupuytren Disease 67 aurora kinase 67 pan HDAC inhibitor 67 DPX Survivac 67 antibody MAb 67 microtubule inhibitor 67 topical gel formulation 67 cannabinor 67 systemic anaplastic large 67 vidofludimus 67 Syncria albiglutide 67 R#/MEM 67 Zybrestat 67 XL# XL# XL# XL# 67 Shows Promise Against 67 Tykerb lapatinib 67 FUSILEV ® 67 Angiotensin Converting Enzyme 67 ELADUR ™ 67 Xelox 67 Presents Preclinical Data 67 Janus Kinase 67 CRMD# 67 Inc. NASDAQ AEZS 67 cetuximab Erbitux R 67 ThermoDox ® clinical 67 Daclizumab 67 Phase lll 67 GATTEX TM 67 tramiprosate Alzhemed TM 67 TRANSDUR ™ 67 Soft Tissue Sarcoma 67 TLK# 67 Presents Preclinical 67 ZACTIMA 67 non constipating irritable 67 nasal decolonization 67 G#DT 67 OTC BB PVCT 67 chronic eosinophilic leukemia 67 Trofex TM 67 Kosan dependence 67 HepeX B TM 67 multicenter Phase II 67 imetelstat GRN#L 67 Canvaxin TM 67 Microplasmin 67 IMPDH inhibitor 67 Azacitidine 67 OMP #R# 67 romazarit 67 Pagoclone 67 Phase IIb III 67 adecatumumab MT# 67 IgG1 monoclonal antibody 67 SoftScan ® 67 RELOVAIR ™ 67 postoperative ileus POI 67 CDK cyclin dependent 67 opioid induced bowel dysfunction 67 Xanafide 67 novel orally inhaled 67 virus HCV protease inhibitor 67 Phase IIa trials 67 TRACON Pharmaceuticals 67 potent suppressor 67 INSPIRE Trial Phase III 67 PF # [002] 67 Second Pivotal Phase 67 Dapagliflozin 67 Oral Calcitonin 67 Orally administered 67 factor VIIa 67 dihydrochloride Tablets 67 IAP inhibitor 67 humanized therapeutic 67 investigational humanized monoclonal antibody 67 agonistic human 67 Pimavanserin 67 refractory metastatic 67 herpetic keratitis 67 PrimeSuite integrates practice 67 PD2i CA Cardiac Analyzer 67 unresectable tumors 67 T1c 67 INxin 67 Tyrosine Kinase Inhibitor 67 Fibrin MB 67 Glucagon Like Peptide 67 small molecule tyrosine 67 thalidomide Thalomid 67 CHAMPION PCI 67 derivatives Radilex TM 67 Zenvia ™ 67 allosteric modulator NAM 67 PHX# 67 GRNVAC1 67 huN# DM1 67 intravenous methylnaltrexone 67 radiation sensitizer 67 drug ISA# 67 SILENOR TM doxepin HCl 67 Injectable Bone Graft 67 histone deacetylase HDAC inhibitor 67 pipeline ImmunoGen collaborators 67 pediatrics neurology 67 Fovea Pharmaceuticals subsidiary 67 IMiDs R 67 Alocrest 67 lenalidomide Revlimid R 67 Ozarelix 67 non splenectomized 67 hypereosinophilic syndrome 66 successfully commercialize Iluvien 66 Friedreich Ataxia FRDA 66 IMiDs ® compound 66 systemic Phase 1b 66 HCV NS5B polymerase 66 Ribavirin causes 66 paclitaxel Taxol R 66 Opterone R 66 Gentamicin Surgical Implant 66 selective immunoproteasome inhibitor 66 BENLYSTA TM 66 5 fluorouracil leucovorin 66 markets HP Acthar 66 TOCOSOL Camptothecin 66 generation PNP inhibitor 66 AFREZZA ® 66 clinical trials SGN 66 gefitinib Iressa 66 intravesical infusion therapy 66 metastatic renal cell 66 cromolyn sodium 66 M# rationally 66 colorectal bladder 66 Stage IIB 66 hyaluronidase enzyme 66 R roscovitine 66 motexafin gadolinium Injection 66 Fx #A 66 deCODE AF TM 66 Receives Orphan Drug Designation 66 PORxin TM 66 subcutaneous immunoglobulin 66 acne impetigo 66 HGS# 66 ZEVALIN ® 66 Targeted Chemotherapy 66 therapeutic monoclonal antibody 66 Commence Phase 66 PEGylated Fab fragment 66 small molecule thrombopoietin 66 cosmetic cosmeceutical products 66 dirucotide MBP# 66 highly purified pasteurized 66 SUTENT ® 66 Tectin TM 66 recurrent herpes labialis 66 chemosensitizer 66 evaluating mipomersen 66 MediGene focuses 66 molecular imaging radiopharmaceuticals 66 vaginally administered lidocaine 66 REG1 Anticoagulation System 66 ATC ovarian cancer 66 coronary stent merged 66 Randomized Phase II 66 novel immunotherapies 66 non nucleoside HCV 66 IL# PE#QQR 66 Shows Statistically Significant 66 Dual Opioid 66 manufactures minimally invasive 66 Systemic Sclerosis 66 neuro inflammatory 66 RANK Ligand inhibitor 66 either acutely decompensated 66 RhuDex ® 66 Luveris R Ovidrel R 66 mucositis ProLindac ™ 66 Transdermal Patch 66 Marqibo TM 66 ASONEP TM 66 ARIKACE ™ 66 aerosolized AAT 66 IV Busulfex 66 sunitinib Sutent 66 pain palliation 66 occlusion PAO 66 Quinamed 66 oncologic diseases 66 signal detection CTSD 66 Amgen Neulasta ® 66 reslizumab 66 TTR amyloidosis 66 Demonstrates Significant 66 CB2 selective receptor agonist 66 rusalatide acetate 66 bladder ovarian 66 POSIDUR TM 66 Omacetaxine 66 evaluating satraplatin 66 CTAP# 66 biased ligand 66 Receives Approvable Letter 66 Zorbtive TM 66 Therapeutic Competitors Companies 66 CA9 SCAN 66 novel histone deacetylase 66 HGS ETR1 66 Cardium Therapeutics TM 66 PDE4 modulators 66 Inotek Pharmaceuticals Corporation 66 DG# compounds targeting 66 Vidaza R 66 compound KOS 66 Pharmacokinetics PK 66 antimitotic 66 P#X# antagonist 66 evaluating tivozanib 66 BHT DNA 66 Xcellerated T Cells 66 Enzastaurin 66 YONDELIS R 66 EOS NASDAQ MELA 66 lumiliximab 66 Dose Ranging Study 66 Letairis ambrisentan 66 SAR# [002] 66 Proxinium 66 Ovitrelle R Serostim 66 aldehyde dehydrogenase ALDH2 deficiency 66 Announces Poster Presentations 66 PLK1 SNALP 66 Brussels THR 66 cisplatin gemcitabine 66 screen Tootsie MASH 66 treatment naive genotype 66 volociximab 66 MGN# 66 Biogen Genentech 66 Shigamabs ® 66 FDA Approvals 66 dose intramuscular 66 hyperphenylalaninemia HPA due 66 treat dysmenorrhea 66 REMINYL ® 66 Vitaxin 66 Thiarabine 66 AFREZZA ™ 66 Slyly witty writer 66 Acute Ischemic Stroke 66 Multiple Ascending Dose 66 trastuzumab DM1 66 tezampanel NGX# 66 thrombin inhibiting aptamer 66 treat refractory angina 66 Proxinium TM 66 triciribine phosphate monohydrate 66 ZFP Therapeutics 66 CTA# Injection 66 AN# topical anti 66 drug GAP #B# 66 anti atherothrombotic 66 Pivotal Study 66 Genentech sanofi aventis 66 mocetinostat MGCD# 66 HuMax TAC 66 metastatic neuroendocrine tumors 66 Shigatoxin producing E. coli 66 Nexavar sorafenib 66 Serostim ® 66 oral taxane 66 nucleoside analog 66 Janus kinase 66 SUCCEED trial 66 PROVENGE ® 66 Phase Ib study 66 oral immunomodulatory 66 ® lenalidomide 66 OMP #M# 66 Initiates Phase 66 Zavesca r 66 investigational HCV polymerase 66 NYSE Amex NBY clinical 66 Unit Dose Budesonide 66 Cetrorelix 66 Gamunex C 66 PEGylated interferon 66 Prodarsan 66 sodium glucose cotransporter 66 erlotinib Tarceva R 66 JAK inhibitor 66 Phase IIb Trial 66 NP2 Enkephalin 66 chronic thromboembolic pulmonary 66 Elotuzumab 66 Onalta TM 66 immunotherapeutic agent 66 Intarcia 66 JAK2 inhibitor 66 AVAX AC Vaccine 66 Troxatyl 66 interferon gamma 1b 66 intranasal formulation 66 Granted Orphan Drug 66 Novolimus 66 Tarvacin Anti Cancer 66 Civacir 66 commercialize ZYFLO CR 66 ERBITUX dermatologic toxicities 66 tubulin inhibitor 66 Onco TCS 66 albiglutide currently 66 include ColorectAlert TM 66 oral talactoferrin 66 rhIGFBP 3 66 Endotoxin Activity Assay 66 FUSILEV enhances 66 ALN HTT 66 AzaSite Plus 66 XmAb 66 ZOLINZA 66 non porcine pancreatic 66 Soliris TM eculizumab 66 lucinactant 66 phase IIa clinical 66 Neulasta R 66 TransVax ™ 66 Phase IIa Clinical Trial 66 psoriasis rheumatoid arthritis 66 Phase 2a clinical trials 66 ENMD # 66 syndrome overactive bladder 66 IMPACT DCM 66 formerly LymphoStat B 66 ancrod 66 clinical trials Archexin 66 Nasdaq MDSO 66 Targretin capsules 66 SAR# [004] 66 NYSE Amex YMI 66 lead Aganocide compound 66 Epothilone D 66 Xyfid TM 66 Oral Fingolimod 66 developing Bicifadine serotonin 66 transgenically produced product 66 pelvic malignancies 66 Trial Evaluating 66 delta gamma agonist 66 Anthracycline 66 ALGRX 66 Vicriviroc 66 benign prostatic hyperplasia enlarged 66 NICE Recommends 66 rheumatoid arthritis thrombocytopenia 66 ImmunoGen TAP technology 66 Recombinant Human 66 plasma kallikrein inhibitor 66 PSN# [002] 66 Androxal TM 66 DDP# 66 BrachySil 66 VP# [004] 66 oral dihydropyrimidine dehydrogenase DPD 66 please visit http:/www.vandapharma.com 66 EGFr expressing metastatic colorectal 66 TAFA# 66 Nasdaq ENMD 66 TNF Tumor Necrosis Factor 66 product platforms GVAX 66 candidate epratuzumab 66 candidates Dyloject TM 66 MPS IVA 66 Augment ™ 66 Cloretazine 66 novel synthetic peptide 66 Entereg TM 66 dermatology therapies 65 Voreloxin 65 EnteroMedics proprietary neuroblocking technology 65 Virulizin ® 65 Xeloda ® 65 dependent kinase inhibitor 65 t2cure GmbH 65 Phase 2a Trial 65 LEVADEX TM 65 refractory NSCLC 65 Deferiprone 65 BiTE R 65 corticosteroid dexamethasone 65 Tasimelteon 65 PLX STROKE targeting 65 Phase IIb Clinical Trial 65 Mg Uk 65 inflammatory cardio metabolic 65 Earns Milestone Payment 65 seliciclib CYC# 65 novel peptide 65 Romiplostim 65 overactive bladder AA# 65 RTP #i 65 Ketotransdel 65 Dyloject TM 65 Surfaxin LS 65 HuMax EGFr 65 octreotide implant 65 hematological cancers notably 65 #I TM# 65 generation radiolabeled antibody 65 metastatic malignant 65 ORENCIA R 65 Boehringer Ingelheim MedImmune 65 metastatic HRPC 65 Sapacitabine CYC# cell 65 MOZOBIL 65 trastuzumab Herceptin R 65 Zolpimist ™ 65 IV NSCLC 65 Aurora Kinase 65 HGS ETR2 65 granted Ortec 65 SILENOR 65 Ceragenin ™ 65 fidaxomicin Phase 65 Gonal f R 65 imatinib Gleevec ® 65 5 HT3 antagonist 65 small molecule glucokinase 65 Glypromate 65 REGN# 65 Urocortin 2 65 DNA methyltransferase inhibitors 65 Empatic TM 65 gemcitabine Gemzar ® 65 Submits NDA 65 CIMZIA TM certolizumab pegol 65 Frozen Shoulder syndrome Adhesive 65 selective phosphodiesterase 65 Pivotal Clinical Trial 65 product AMD# 65 individualized cellular immunotherapy 65 p# inhibitor 65 EndoTAG 65 candidate SUVN 65 rheumatoid arthritis psoriasis 65 Cloretazine VNP#M 65 developing ostarine selective 65 non nucleoside inhibitor 65 Accelerated Partial Breast Irradiation 65 Infusion Reactions Severe 65 PROGENSA R 65 REMOXY ® 65 Phase 2b Trial 65 BiovaxID TM 65 Cutaneous T 65 oral rivaroxaban 65 Phase #/#a 65 acetylgalactosamine 6 65 registrational trial 65 bevacizumab Avastin ® 65 HIV integrase inhibitors 65 ophthalmology dermatology cardiovascular disease 65 HDL Selective Delipidation 65 taxane resistant 65 fibrosis oncology 65 fosbretabulin 65 INTERCEPT red 65 buccal spray 65 keloid scarring 65 VBLOC ™ 65 includes TOLAMBA TM 65 triggers apoptosis programmed 65 transthyretin TTR mediated amyloidosis 65 Pertuzumab 65 GSK# [002] 65 Anticancer Compound 65 Deforolimus 65 oncology radiation oncology 65 Therapeutic Vaccine 65 Intermezzo ® zolpidem tartrate 65 overactive bladder syndrome 65 preclinical efficacy 65 phase IIb study 65 rheumatoid arthritis psoriatic arthritis 65 OMNARIS HFA 65 3 registrational trial 65 Pafuramidine 65 XOMA 3AB 65 oral Janus kinase 65 treatment naïve genotype 65 BR.# 65 CYP#A# CYP#D# 65 ORENCIA ® 65 relapsing remitting MS RRMS 65 Pharmos pipeline 65 apomorphine hydrochloride 65 vaginal candidiasis 65 Talotrexin 65 EVIZON TM squalamine lactate 65 paclitaxel Taxol ® 65 candidate REP# 65 recurrent metastatic 65 ImmunoVEX 65 alemtuzumab Campath 65 Cetuximab Erbitux 65 Fabry Disease 65 CCR5 mAb 65 TKM ApoB 65 Peyronie disease Frozen Shoulder 65 Delta opioid receptor 65 Drug Shows Promise 65 Inhalation Solution 65 XL# XL# XL# 65 ERYtech 65 iobenguane 65 TÎ ² 4 65 metastatic gastric 65 diabetes sciatica 65 Zingo TM 65 ATRA IV 65 Ridaforolimus 65 Submits IND 65 Study Evaluating 65 Alessandro Riva 65 tumor angiogenesis inhibitors 65 accumulate preferentially 65 behavioral neurobiology 65 NuroPro R 65 azilsartan medoxomil 65 Tezampanel 65 solanezumab 65 Interferon beta 65 Manja Bouman CEO 65 Perforomist TM formoterol fumarate 65 Triapine R 65 Talabostat